These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 28550637)

  • 21. Cerebrovascular remodeling and epilepsy.
    Marchi N; Lerner-Natoli M
    Neuroscientist; 2013 Jun; 19(3):304-12. PubMed ID: 23072899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epilepsy and the blood-brain barrier.
    Duncan R; Todd N
    Br J Hosp Med; 1991 Jan; 45(1):32-4. PubMed ID: 2009437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 1 diabetes exacerbates blood-brain barrier alterations during experimental epileptic seizures in an animal model.
    Yorulmaz H; Kaptan E; Seker FB; Oztas B
    Cell Biochem Funct; 2015 Jul; 33(5):285-92. PubMed ID: 26011758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood-brain barrier, bulk flow, and interstitial clearance in epilepsy.
    Marchi N; Banjara M; Janigro D
    J Neurosci Methods; 2016 Feb; 260():118-24. PubMed ID: 26093166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy and the blood-brain barrier.
    Cornford EM; Oldendorf WH
    Adv Neurol; 1986; 44():787-812. PubMed ID: 3085437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target.
    Mukhtar I
    Seizure; 2020 Nov; 82():65-79. PubMed ID: 33011590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug resistance in epilepsy: the role of the blood-brain barrier.
    Abbott NJ; Khan EU; Rollinson CM; Reichel A; Janigro D; Dombrowski SM; Dobbie MS; Begley DJ
    Novartis Found Symp; 2002; 243():38-47; discussion 47-53, 180-5. PubMed ID: 11990780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models.
    Uchida Y; Ohtsuki S; Terasaki T
    Drug Metab Dispos; 2014 Oct; 42(10):1719-26. PubMed ID: 25061162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms underlying blood-brain barrier dysfunction in brain pathology and epileptogenesis: role of astroglia.
    Kovács R; Heinemann U; Steinhäuser C
    Epilepsia; 2012 Nov; 53 Suppl 6():53-9. PubMed ID: 23134496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of blood-brain barrier in temporal lobe epilepsy and pharmacoresistance.
    van Vliet EA; Aronica E; Gorter JA
    Neuroscience; 2014 Sep; 277():455-73. PubMed ID: 25080160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasticity of antiepileptic drug targets.
    Beck H
    Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signaling to P-glycoprotein-A new therapeutic target to treat drug-resistant epilepsy?
    Hartz AM; Notenboom S; Bauer B
    Drug News Perspect; 2009 Sep; 22(7):393-7. PubMed ID: 19890496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.
    Grewal GK; Kukal S; Kanojia N; Saso L; Kukreti S; Kukreti R
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms of drug resistance in epilepsy].
    Lasoń W
    Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory pathways of seizure disorders.
    Marchi N; Granata T; Janigro D
    Trends Neurosci; 2014 Feb; 37(2):55-65. PubMed ID: 24355813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase.
    Danjo S; Ishihara Y; Watanabe M; Nakamura Y; Itoh K
    Brain Res; 2013 Sep; 1530():44-53. PubMed ID: 23831997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paroxysmal slow cortical activity in Alzheimer's disease and epilepsy is associated with blood-brain barrier dysfunction.
    Milikovsky DZ; Ofer J; Senatorov VV; Friedman AR; Prager O; Sheintuch L; Elazari N; Veksler R; Zelig D; Weissberg I; Bar-Klein G; Swissa E; Hanael E; Ben-Arie G; Schefenbauer O; Kamintsky L; Saar-Ashkenazy R; Shelef I; Shamir MH; Goldberg I; Glik A; Benninger F; Kaufer D; Friedman A
    Sci Transl Med; 2019 Dec; 11(521):. PubMed ID: 31801888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiopep-conjugated electro-responsive hydrogel nanoparticles: therapeutic potential for epilepsy.
    Ying X; Wang Y; Liang J; Yue J; Xu C; Lu L; Xu Z; Gao J; Du Y; Chen Z
    Angew Chem Int Ed Engl; 2014 Nov; 53(46):12436-40. PubMed ID: 25044856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
    Orlandi A; Paolino MC; Striano P; Parisi P
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.